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Bradykinin contributes to immune liver injury via B2R receptor-mediated 
pathways in trichloroethylene sensitized mice: a role in Kupffer cell activation 
Jiaxiang Zhanga,b, Haibo Xieb, Na Lib, Ling Yanga, Yi Yangb, Hui Wangc, 
 Changhao Wud, Tong Shenb,#, Qixing Zhua,# 
Abstract: We have previously shown trichloroethylene (TCE) induced occupational 
medicamentosa-like dermatitis due to TCE (OMLDT) with immune liver injury, and 
kallikrein-kinin system (KKS) activation as a probably mechanism underlying the 
immune damage. Bradykinin (BK) is an important active component of KKS system 
function, but the specific role of BK in the immune liver injury has never been 
examined. The present study aimed to explore the important role of BK and 
mechanisms of action in immune liver injury induced by TCE. TCE sensitization 
significantly increased the expression of BK receptor (B2R) in the liver. Compared to 
blank and vehicle control group, TCE sensitization positive mice developed 
exacerbated liver injury evidenced by elevated AST, ALT levels and hepatocyte 
damage. TCE sensitization also stimulated MAPK and STAT3 activation in liver 
tissue. B2R antagonist HOE140 ameliorated these changes. Kupffer cells (KCs) of the 
liver were also activated following TCE sensitization; both CD68+ KCs and 
CD16/CD32+ M1 type KCs were increased in TCE positive group. Further 
experiments isolated the KCs from the liver in each group and showed that TCE 
sensitization resulted activation of MAPK signal pathway which in turn caused 
release of the pro-inflammatory cytokines, IL-1β, IL-6, TNF-α, in KCs; the antagonist 
HOE140 again decreased these changes in KCs. These results uncover a novel role of 
BK and B2R cross-talk in KCs activation in TCE sensitized mice, mediated by 
pro-inflammatory cytokine release via MAPK and STAT3 activation, contributing to 
the immune liver injury.  
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1. Introduction 
Trichloroethylene (TCE) is a volatile and non-flammable lipophilic liquid of the 
chlorinated aliphatic solvent family (Dumas et al., 2018). TCE is mainly used as a 
solvent to remove grease from metal parts or lenses in industrial production (Xueqin 
et al., 2018). It is also widely used as a chemical intermediate and extractant in 
chemical, dry-cleaning and textile industries (ATSDR, 2006). TCE came into 
intensive commercial production in the United States and Germany in the 1920s, and 
the scale of the production reached hundreds and thousands of tons every year 
(NICNAS, 2000). Workers exposed to TCE develop occupational medicamentosa-like 
dermatitis due to TCE (OMLDT), also called TCE hypersensitivity syndrome (THS). 
THS is characterized by fever, generalized rash, liver dysfunction and superficial 
lymphadenopathy (Zhang et al., 2017). There is consistent data to indicate that TCE 
has also kidney and liver toxicity.  However, the mechanism of the organ injury in 
THS is unknown.  
Many clinical studies have found that OMLDT patients exhibit changes in 
complement system and a variety of cytokines, but the mechanism remains unclear 
(Zhang et al., 2017; Xueqin et al., 2018). A previous study shows that complement C3 
can act as a substrate for kallikrein (KLK) -mediated inflammatory response. Through 
the activation of C3, KLKs promote complement activation in local tissues in the 
process of innate immunity. Conversely, inhibition of complement activation by  
c1-inh can also suppress the activity of KKS system (Oikonomopoulou et al, 2013). 
In our previous studies, we have found that kallikrein-kinin system (KKS) plays an 
important role in organ injury in trichloroethylene-sensitized mice (Wang et al., 2016; 
Wang et al., 2015). The mechanism however is unclear. The level of BK reflects the 
strength of the KKS in immune activities. BK generated by plasma kallikrein 
proteolytic action on high-molecular-weight kininogen (HK), primarily mediates KKS 
actions. BK can be found in the blood, but can also be produced locally in many 
tissues. BK is a vasodilator peptide with pro-inflammatory actions via its membrane 
receptor, bradykinin B2 receptor (B2R), a G protein-coupled receptor (Ricciardolo et 
al., 2016). B2R has been shown to mediate the proinflammatory effect promoted by 
BK (Terzuoli et al., 2018). Many researchers show that BK and B2R activate the 
pathways of extracellular signal-regulated kinase (ERK) and p38 mitogen-activated 
protein kinase (MAPK) (Izumi et al., 2018). ERK and p38 MAPK activation are 
known to increase gene expression of inflammatory cytokines such as tumor necrosis 
factor-α (TNF-α) and interleukin-6 (IL-6). The cytokines important in the 
inflammatory response, such as TNF-α and IL-6, on the other hand, have been 
reported to activate the pathways of extracellular signal-regulated kinase (ERK) and 
p38 mitogen-activated protein kinase (MAPK) (Izumi et al., 2018; Meng et al., 2005). 
Kupffer cells (KCs) are a specific type of resident macrophages in the liver and are 
the main cells of the innate immune system in this tissue. KCs are divided into two 
types, M1 (CD16/CD32+) and M2 (CD206+). M1-type KCs secrete proinflammatory 
cytokines (such as TNF-α, IL-1β, IL-6, IL-12); M2-type KCs have a weak antigen 
presentation ability and counteract the immune response by secreting potent 
immunosuppressive factors, such as IL-10. (Zeng T, et al., 2016). The release of 
pro-inflammatory cytokine by KCs relies on the inflammatory signaling pathway 
molecules p38 MAPK, NF-κB and STAT3 in liver (Liu et al., 2015; Seo et al., 2018). 
To date, whether TCE sensitization leads to BK activation in the liver and whether BK 
exerts an effect on Kupffer cells and causes a release of proinflammatory cytokines 
through MAPK related pathways have not been examined. Answers to these questions 
will provide molecular insight into KKS-mediated immune mechanisms in liver injury 
due to TCE sensitization. 
To reveal the molecular mechanisms of KKS activation in immune liver injury due to 
TCE sensitization, we examined the KCs activation in BALB/c mice sensitized by 
TCE based on our previous experiments. In the present study, we used a specific B2R 
antagonist, HOE140, to dissect the BK/B2R signaling pathway mediating the immune 
liver injury in TCE sensitized mice. Furthermore, we isolated the KCs from the liver 
in these TCE sensitization mice and investigated MAPK and STAT3 pathway 
activation and its associated cytokine release.  
 
2. Materials and Methods 
2.1 Animals 
A total of 110 female BALB/c mice at 6-8-week-old were purchased from 
Experimental Animal Center of Anhui Medical University, weighing between 17.3 
and 25.4g. The animals were housed in certified barrier facilities in micro-isolation 
cages with five animals per cage at room temperature, and freely accessed a standard 
mouse food and water on a 12-h-light/12-h-dark cycle every day. The experimental 
protocol and the use of animals were approved by the Animal Care and Use 
Committee of Anhui Medical University. The mice were randomly divided into four 
groups: blank control group (n=5), vehicle (olive oil and acetone) control group (n=5), 
TCE-treated groups (TCE group) (n=48), TCE and B2R antagonist-treated groups 
(TCE + HOE140 group) (n=52). 
2.2 Reagents 
TCE and Freund’s complete adjuvant (FCA) were purchased from Sigma (St. Louis, 
MO, USA); acetone and olive oil were purchased from the Shanghai Chemical 
Reagent Company. HOE140 was from TOCRIS bioscience (Avonmouth, Bristol, 
United Kingdom). Goat anti-mouse BK polyclonal IgG antibody was purchased from 
Santa Cruz (CA, USA), rabbit anti-mouse B2R antibody from Abcam (Cambridge 
Science Park, UK), the second antibody donkey anti-goat IgG H&L (Alexa Fluor® 
594) and donkey Anti-Rabbit IgG H&L (Alexa Fluor® 488) were purchased from 
Abcam (Cambridge Science Park, UK), 4, 6-diamidino-2-phenylindole (DAPI) from 
Sigma (St. Louis, MO). Immunohistochemistry kits were purchased from ZSJQ-BIO 
(Beijing, China). Rabbit anti-mouse CD68, TNF-α, IL-1β and IL-6 polyclonal IgG 
antibodies were purchased from Bioss (Beijing, China). Rat anti-mouse CD16/CD32 
polyclonal IgG antibody was purchase from R＆D systems (Minneapolis, USA). 
Other notable reagents/supplies purchased were: Revert Aid First Strand cDNA 
Synthesis Kit (Thermo Scientific, Pittsburgh, PA), Histostain Plus and DAB substrate 
kits (ZSJQ, Beijing, China), RIPA buffer (Beyotime Biotechnology, Beijing, China) 
containing PMSF (Beyotime Biotechnology, Beijing, China), 0.45um PVDF 
membrane (GE healthcare, Germany), collagenase (type IV, Sigma-Aldrich, St. Louis, 
USA), Percoll (Sigma-Aldrich, St. Louis, USA), The BK, IL-1β, IL-6 and TNF-α 
ELISA kit (USCN, China), and Light Cycler 480 SYBR Green I Master kit (Roche, 
Basel, Switzerland).  
2.3 Animal model and experiment grouping design  
A BALB/c mouse model of TCE sensitization was generated as reported previously 
(Wang et al., 2015). On Day 1, the mice in the TCE-treat group were intradermally 
injected with 100 μl of a mixture of 50% TCE (TCE : olive oil : acetone=5:2:3, 50 μl) 
and FCA (50 μl) for the first stimulation. A 100 μl of 50% TCE was painted on the 
shaved area of dorsalis for continued sensitization on the 4th, 7th, and 10th day. A 
week later, 100μl of 30% TCE (TCE : olive oil : acetone =3:2:5) was painted twice to 
challenge the dorsal skin on 17th and 19th days. TCE + HOE140 group followed the 
same protocol as the TCE group except intraperitoneal injection of HOE140 (0.1 
mg/kg) 1h before the TCE challenge on the 17th and 19th days (Gama et al., 2004). In 
the vehicle control group, mice were treated similarly with the same proportions of 
olive oil and acetone without TCE. The blank control group received no treatment. 
The shaved area of each mouse was covered with filter paper and sealed with 
nonirritating tape for 24 hours after panting. On the 20th day, 24 hours after the last 
challenge, the cutaneous reactions of the dorsal skin were scored on a 4-point scale: 0, 
no reaction; 1, scattered mild redness; 2, moderate and diffuse redness; and 3, 
intensive erythema and swelling. If the cutaneous reaction score of any animal was 
equal to 1 or greater, it was judged as a positive reaction and classified as sensitization 
positive or otherwise as sensitization negative. Blood, liver and other samples were 
collected according to experimental requirements after the mice were euthanized at 
20th day (24h time point) and 22nd day (72 h time point). Additional blood samples 
were collected into Vacutainer tubes which contained EDTA and aprotinin (0.6 
TIU/ml blood) to inhibit proteinase activity. The blood was centrifuged to separate 
plasma from blood cells and plasm was transferred into polypropylene tubes. 
Thereafter all the specimens were grouped as follows, blank control group, vehicle 
control group, 24h TCE positive group, 24 TCE negative group, 72h TCE positive 
group, 72 TCE negative group, 24h TCE + HOE140 positive group, 24h TCE + 
HOE140 negative group, 72h TCE + HOE140 positive group, and 72h TCE + 
HOE140 negative group. The schematic protocol is shown in Figure 1. 
2.4 Determination of liver enzyme activity 
The blood was collected from eye vein plexus, and then centrifuged at 3000 rpm for 
15 min at 4℃. Activities of the serum enzymes alanine aminotransferase (ALT) and 
aspartate transaminase (AST) were determined by automatic biochemistry analyzer. 
2.5 Transmission electron microscopy (TEM) examination of liver tissue  
Rice grain size fresh liver tissue from the same site of the liver in each mouse was 
fixed in 0.1mol/l glutaraldehyde-paraformaldehyde solution for 10h and made into 
specimens. The specimen sections were then examined by transmission electron 
microscope and pictures were taken. 
2.6 Isolation of liver KCs   
Liver KCs were isolated by in situ collagenase perfusion and differential 
centrifugation on Percoll density gradient as described previously (Hansen et al., 2002; 
Wu et al., 2016). Briefly, a 20-G catheter was put into the portal vein, and the inferior 
vena cava cut. The liver was perfused with PB, a mixture of digestion buffer: 1× PBC, 
collagenase, Pronase E, and 4.76 mM CaCl2. After digestion, the liver was minced 
and triturated in BSA solution (1× PBC, supplemented with 0.5% FBS). The tissue 
suspension was passed through a 200-mesh cell strainer, and the single cells isolated. 
The cells were then fractionated by using 25% Percoll and 50% Percoll. The cell 
suspension was washed and allowed for adhesion to the culture dish. The KCs were 
able to adhere to the plastic, whereas the nonadherent fraction was washed away in 
DMEM with 10% FBS. The KCs from 2 mice (equal scores) were pooled, given the 
limited number of KCs available from each animal for RNA and protein isolation. 
2.7 Double immunofluorescence detection for BK in combination with B2R 
Fresh liver specimens were fixed in 10% formalin, dehydrated, embedded in paraffin 
and cut into 2μm thick slices. The sections were then deparaffinized in xylenes and 
rehydrated by a graded series of alcohols, followed by antigen retrieval and 
incubation in a blocking buffer containing 5% goat serum in 0.1 mmol/l PBS for 2 
hours (pH, 7.4). Then sections were incubated with a mixture of goat anti-mouse BK 
polyclonal antibody (1:400) and rabbit anti-mouse B2R antibody (1:200) at room 
temperature for 1 h, and then left at 4 °C overnight. On the next day, the sections were 
warmed up in room temperature for 30min, washed with PBS and incubated with 
fluorescence-labeled secondary antibodies – a mixture of donkey anti-goat IgG H&L 
(Alexa Fluor® 594, 1:1000) and donkey anti-Rabbit IgG H&L (Alexa Fluor® 488, 
1:1000) for 2 h. The sections were then washed in PBS and the nucleus was 
counter-stained with DAPI for 15min. BK and B2R binding was examined using an 
inverted fluorescence microscope with appropriate excitation and emission filters.  
2.8 Western blot for B2R, MAPK pathway molecules and STAT3 protein  
Liver tissues and isolated KCs were homogenized with RIPA buffer (Beyotime 
Biotechnology, Beijing, China) containing PMSF (Beyotime Biotechnology, Beijing, 
China) and phosphatase inhibitors (10mM NaF, 1mM Na3VO4, 1mM Na2P2O4). After 
determination of protein concentrations, a total of 50 μg protein was put for 
electrophoresis via 15% sodium dodecyl sulfate-polyacrylamide gel before being 
transferred to PVDF membranes. The membranes were blocked in 5% non-fat 
powdered milk in Dulbecco’s PBS (DPBS) for 2 h at room temperature. Thereafter, 
the membranes were incubated with B2R antibody (1:500), P38, p-P38, ERK1/2, 
p-ERK1/2, JNK, p-JNK, STAT3, p-STAT3 (1:1000) antibodies and GAPDH (1:1000) 
antibody overnight. On the next day, the membranes were washed in DPBS 
containing 0.05% Tween-20 three times and in DPBS once, each for 10 min, and then 
incubated with goat anti-rabbit IgG antibody for 2 h. Thereafter, the membranes were 
washed three times in DPBS containing 0.05% Tween-20 and in DPBS once. Finally, 
the signal was developed using an enhanced chemiluminescence (ECL) detection kit 
from Pierce Biotechnology (Rockford, USA). The densitometry of the signal was 
analyzed by Image-Pro plus software 6.0 (Media Cybernetics, Inc., Rockville, MD, 
USA). 
2.9 Total RNA extraction and quantitative real-time PCR (qRT-PCR) for gene 
expression 
Total RNA was extracted from KCs using TRIzol reagents. The RevertAid First 
Strand cDNA Synthesis Kit was used to produce cDNA. The cDNA obtained was 
amplified by PCR in a Light Cycler 480 system using the primers shown in Table 1. 
The amplification protocol was: initial denaturation at 95 °C for 10min, followed by 
45 cycles, including 95 °C for 15 sec, 60 °C for 15 sec and 72 °C for 20 sec. The 
relative level of gene expression was analyzed by the 2-ΔΔCt method. The fold-change 
in IL-1β, IL-6 and TNF-α mRNA in the samples was normalized to GAPDH levels.  
2.10 ELISA assay  
The BK concentration in mouse serum was determined using USCN mouse ELISA kit. 
All reagents, samples and standards were prepared as instructed. 100 μl standard or 
sample was added to each well and incubated 1.5 h at 37 °C. Next, 100 μl of prepared 
biotin antibody was added to each well and samples were incubated for 1 h at 37 °C. 
100 μl of prepared streptavidin solution was added and the plate was incubated for 30 
min at 37 °C. Thereafter, 100 μl of TMB one-step substrate reagent was added to each 
well with 15 min incubation at 37 °C in dark. The reaction was finally stopped by 
adding 50 μl stop solution to each well. The absorbance at 450 nm in each well was 
immediately measured using a Thermomax microplate reader. All experiments were 
performed in triplicate.  
2.11 Immunohistochemistry (IHC) staining  
Fresh liver specimens were fixed in 10% formalin, dehydrated, embedded in paraffin 
and cut into 5-μm-thick slices. The sections were then deparaffinized in xylenes and 
rehydrated by a graded series of alcohols. Endogenous peroxidase was inhibited by 
incubation with 3% H2O2 for 15 min. Slides were immersed in 0.01M sodiumcitrate 
buffer for antigen retrieval in a microwave oven. The sections were incubated with 
anti-CD68, IL-1β, IL-6 and TNF-α antibodies overnight at 4 °C after blocking 
non-specific binding with 5% normal goat serum in PBS for 15 min. On the morning 
of the next day, the sections were processed with Histostain Plus kit and DAB 
substrate kit for peroxidase reactions. Images were captured using an Olympus 
microscope. Image-Pro Plus version 6.0 software (Media Cybernetics, Inc., Rockville, 
MD, USA) was used to assess the area and density of the dyed region, and the 
integrated optical density (IOD) value of the IHC section. The mean densitometry of 
the digital image (magnification, ×400) was designated as representative DAB 
staining intensity. The signal density of the tissue areas from five randomly selected 
fields was counted in a blinded manner and subjected to statistical analysis. 
2.12 Statistical Analysis 
All data are expressed as the mean ± SD and the statistical analysis was performed 
with SPSS 23.0, the professional statistical analysis software. A one-way analysis of 
variance (ANOVA) followed by a post-hoc least-significant test (LSD) and Dunnett 
test were used to examine the difference between the groups. A p value <0.05 was 
considered as statistically significant.  
 
3. Results 
3.1 Sensitization rates  
Based on the cutaneous reaction scores, the mice were divided into 
sensitization-positive (positive) and sensitization-negative (negative) groups on the 
20th day. Sensitization rates were calculated (as number of redness or swelling / 
number of mice) in both TCE group and TCE + HOE140 group. The sensitization rate 
was 39.58% (19/48 positive) in the TCE group and 32.69% (17/52 positive) in the 
TCE + HOE140 group. The difference between the two groups was not significant. 
3.2 CD68 and CD16/CD32 detection in liver by IHC 
CD68 is a highly glycosylated membrane protein. When KCs are activated, CD68 
expression is increased and hence used as marker for KC activation. CD16/CD32 are 
M1 type KCs marker. The CD68+ and CD16/CD32+ cells in liver tissue were 
therefore assessed by IHC staining in the current TCE mouse model. Data showed 
increased CD68+ cells in liver tissue in each TCE positive group compared with blank 
control group and vehicle control group (Figure 2), suggesting KC activation in liver 
tissue by TCE sensitization.  
3.3 Expression of BK in plasma  
There was no significant difference in BK level between the blank control and vehicle 
control groups. However the plasma BK level was increased in 72h TCE and TCE + 
HOE104 groups compared to the blank control group, with statistical significance 
(P<0.05, Figure 3).  
3.4 Expression of B2R protein in liver 
The 72h time point was chosen to detect the protein expression of B2R as the liver 
injury was the most severe at this time point. The B2R level was increased by 6~8 
folds in 72h TCE positive group compared with than blank control, vehicle control 
group and 72h TCE negative group, showing marked B2R upregulation specific to 
TCE sensitization. The absolute mean value of B2R expression in 72h TCE + HOE 
positive group was slightly lower than that in 72h TCE positive group, but with no 
statistical significance (Figure 4). 
3.5 HOE140 intervention demonstrating BK and B2R interaction 
HOE140, a specific antagonist of B2R, was used to examine the binding of BK to 
B2R using fluorescence double-labeling of both molecules. Imaging data showed the 
BK and B2R binding in TCE sensitization positive liver (saffron yellow), and the 
binding was separated in TCE + HOE140 positive liver (red and green) (Figure 5). 
The results show that HOE140 prevented the interaction of BK with B2R.  
3.6 Liver injuries in TCE sensitized mice 
Serum ALT and AST activity was quantified as hepatic function. There was no 
significant difference between blank control group and vehicle control group. 
Compared to the blank control group, the serum AST was significantly higher in 24h 
and 72h TCE positive groups. The serum ALT in 72h TCE positive group was also 
significantly higher than that in blank control group (Figure 6).  
The transmission electron microscopic examination showed no significant difference 
between the blank control and vehicle control group. In the liver tissue from 24h and 
72h TCE positive group, there were a loss of intracellular organelles, appearance of a 
large number of vacuoles, loss of mitochondria and significant reduction of glycogen 
particles in hepatocytes.However, these histomorphological changes were alleviated 
in 24h and 72h TCE + HOE140 positive group and hepatocyte ribosome was only 
partially reduced. Vacuolar degeneration was seen in a small number of mitochondria, 
while most of the mitochondria clearly had normal morphology in 72h TCE + 
HOE140 positive group (Figure 7). These data clearly show that TCE sensitization 
caused significant cellular and sub organelle damages in hepatocytes and blocking 
B2R receptor by HOE140 antagonized these changes. 
3.6 MAPK and STAT3 protein expression in liver 
The expression MAPK and STAT3 signaling pathway proteins in the liver was 
determined. P38, ERK1/2, JNK and STAT3 expression showed no significant 
difference in all groups. The expression of phosphorylated protein, p-P38, p-ERK1/2, 
p-JNK and p-STAT3, in liver showed no significant difference between the blank 
control group and the vehicle control group. However, these phosphorylated proteins 
were increased significantly in 72h TCE positive group except p-P38, showing 
phosphorylation and hence activation of these MAPK and STAT3 signaling proteins 
following TCE sensitization. Of interest, the expression of the phosphorylated 
proteins in 72h TCE + HOE140 group returned to the normal level which was close to 
that in 72h TCE negative group (Figure 8), suggesting that blocking BR2 receptor 
inhibited activation of these MAPK and STAT3 proteins. These parallel changes in 
both hepatocyte damages and MAPK and STAT3 signaling proteins following B2R 
antagonism support the involvement of MAPK and STAT3 pathways in hepatocellular 
damage in TCE sensitization. 
3.7 MAPK protein expression in isolated KCs 
To further explore the role of MAPK signal pathway activation in KC function in 
immune liver injury sensitized by TCE, the KCs were directly isolated from liver 
tissue and the protein expression was determined by western blot in blank control, 
vehicle control and 72h time point groups. In contrast to the measurement in liver 
tissue, p-P38 expression was significantly high in 72h TCE positive group. The 
p-ERK1/2 and p-JNK expressions in KCs also increased in 72h TCE positive group, 
similar to findings in liver tissue. However, HOE140 reduced the stimulated 
expression of p-P38, p-ERK1/2 and p-JNK significantly in TCE positive group 
(Figure 9), suggesting involvement of BR2 in activation of these signaling proteins in 
KCs. 
3.8 Proinflammatory cytokine release from KCs and their deposition in liver tissue 
To explore the downstream signaling pathways, the deposition of KC-related 
cytokines, IL-1β, IL-6 and TNF-α, in the liver tissue was examined in each group by 
IHC. The results showed that the cytokine deposition was enhanced at 24h and 72h 
TCE positive groups. Compared to 72h TCE positive group, the expression of IL-1β, 
IL-6 and TNF-α was reduced in 72h TCE + HOE140 positive group (Figure 10, 11, 
12). Further experiments measured IL-1β, IL-6 and TNF-α mRNA expressions 
directly in KCs by qRT-PCR. The results showed that the mRNA expression of IL-1β, 
IL-6 and TNF-α levels was markedly increased in KCs from 72h TCE positive group. 
Again, HOE140 alleviated the simulated mRNA expression of these cytokines in KCs 
from 72h TCE + HOE140 positive group mice (Figure 13). The cytokine expression 
in KCs was similar to the deposition in liver. These data together suggest a 
mechanism whereby increased expression of these key KC derived cytokines and 
their release into liver tissue promoting inflammatory reactions. 
4. Discussion 
TCE has long been recognized as an occupational and environmental pollutant and it 
induces OMLDT among exposed workers. OMLDT is an autoimmune disease, which 
has become one of the major occupational health problems in some countries (Liu et 
al., 2015; Zhang et al., 2017). In recent years, liver injury of OMLDT is receiving 
increased attention in the public health field. However, the mechanism of action is not 
fully understood(Zhang et al., 2018; Venkatratnam et al., 2018; Zhou et al., 2017). 
Many clinical data suggest involvement of type IV allergic reactions or delayed type 
hypersensitivity in OMLDT (Jia et al., 2012). However, increasing evidence suggest 
that type IV allergic reactions cannot fully explain the multi-organ injuries induced by 
TCE, especially in liver injury (Zhang et al., 2013). Several studies suggest that the 
liver injury induced by TCE is due to immune injury (Tang et al., 2008; Bradford et 
al., 2011). Macrophages activation was also observed in TCE treated MRL+/+ mice 
(Cai et al., 2007). Of significance, we found that KCs (CD68+) were activated in TCE 
sensitized mice in the present study. We further examined the increased expression of 
M1-type KCs, CD16/CD32, in the liver. An important finding is that CD16/CD32 
expression was increased in TCE positive group. This supports TCE sensitization 
stimulating the activation of M1 type KCs as an immune response in liver tissue. The 
finding suggests that KCs and a release of KC-related cytokines are important 
intermediate steps in immune liver injury induced by TCE. This begs a further 
question how KCs and their secreted cytokines are regulated. In our previous study, 
we found KKS activation and plasma BK expression increased significantly in TCE 
sensitized mice (Wang et al., 2016). Many studies have revealed BK stimulated 
macrophage activation and induced inflammatory cytokine expression in immune 
injury in other tissues (Feng et al., 2016; Vorlova et al., 2016; Desposito et al., 2015). 
In the present study, we examined the BK and B2R expression in the liver from TCE 
sensitized mice. We found BK was increased significantly in TCE positive group. 
Consistent with BK rise, B2R expression was also increased in 72h TCE positive 
group. These data suggest that BK release and its action on B2R may occur following 
TCE sensitization. The next question is how the BK and B2R interaction contributes 
to the immune liver injury following TCE sensitization.  
To establish a causal relationship, we selected specific potent BK receptor (B2R) 
antagonist, HOE140, to investigate the pathophysiological role of BK and B2R in 
vivo. To ascertain the antagonist effect via the specific interaction between BK and its 
receptor B2R, we performed fluorescent double-labeling that showed co-localization 
of BK and B2R in the TCE positive liver tissue but separation of these two molecules 
after the antagonist treatment. To establish the relevance of BK and B2R interaction to 
liver damage, we examined changes to key liver function enzymes AST and ALT and 
direct histopathology. AST and ALT were increased significantly in TCE positive 
groups, compared to blank control and vehicle control group. Transmission electron 
microscopic examination showed loss of hepatocyte intracellular organelles, 
formation of a large number of vacuoles, loss of mitochondria and reduced glycogen 
particles in 24h and 72h TCE positive group. . All these results provide strong 
evidence that TCE sensitization can induce liver injury. Of great interest, the liver 
injury that manifested as above was attenuated by HOE140, evidenced by a recovery 
of histomorphological changes, and decreased levels of AST and ALT in mice 
pretreated with the antagonist, compared with its corresponding TCE positive mice. 
The results show a protective effect by HOE140 and supports a key role for B2R in 
TCE-sensitization induced liver injury.  
We have also explored what pathway(s) were involved leading to the inflammatory 
response after the BK and B2R interaction. Previous studies have revealed that BK 
significantly increased p-ERK1/2 MAPK (Li et al., 2017), p-JNK MAPK (Frigolet et 
al., 2017) and STAT3 (Breit et al., 2015) in other tissues. Activation of the MAPKs, 
including ERK1/2, JNK, leads to phosphorylation and activation of P38 transcription 
factors present in the cytoplasm or nucleus, which initiates the inflammatory response 
in other tissues (such as IL-1, TNF-α, and IL-6) (Pearson et al, 2001; Chen et al., 2017. 
The highly conserved JAK-STAT pathway involves regulation of the expression of 
diverse cytokines and activates the STAT proteins that are translocated into the 
nucleus and bind target gene promoter regions to regulate transcription of 
inflammatory genes (Boengler et al., 2008). We have, therefore, examined the 
expression of key MAPK and STAT3 pathway proteins following TCE sensitization in 
our experimental model, with or without B2R antagonist treatment. The results 
showed increase of p-ERK, p-JNK and p-STAT3 as result of activation of their 
inactive protein forms by TCE sensitization in liver tissue. Specifically, blocking the 
BK receptor with its antagonist reduced the stimulated expressions of these proteins, 
showing involvement of BK and B2R interaction in activating these pathways. 
Although we did not observe a difference in P38 and its phosphorylated protein – a 
major protein that regulates inflammation and cytokine of MAPK cascade, the 
difference was clearly shown in KCs as discussed later. KCs are the main cells which 
secrete the proinflammatory cytokines in liver, such as IL-1, TNF-α, TGF-β and IL-6.  
We have asked the next question about the down-stream mechanisms leading to 
inflammatory damage in liver tissue. Thus, we isolated the KCs from the liver tissue 
and measured the MAPK protein and cytokine mRNA expressions in each group. 
Indeed, p-P38 was increased significantly in 72h TCE positive group, and HOE140 
alleviated the stimulated p-P38 protein increase, as well as the p-ERK and p-JNK 
expression. These data support a mechanism that BK binding to its receptor activates 
the MAPK pathways in KCs and liver tissue. The cytokine mRNA measurement 
showed that IL-1β, IL-6 and TNF-α mRNA expressions were increased significantly 
in KCs from 72h TCE positive liver. These cytokine changes were also alleviated 
after the block of B2R. We also investigated the changes of the key pro-inflammatory 
cytokines IL-1β, IL-6 and TNF-α in liver tissue and obtained data similar to those in 
KCs. It is noteworthy that KCs’ activation induces the secretion of IL-1β, IL-6 and 
TNF-α (Figure 14). The results were corroborated by data from a previous 
epidemiological study where TNF-α, interferon (IFN)-γ, IL-6 and IL-10 
concentrations were remarkably higher in the OMLDT patients than in the healthy 
workers (Kamijima et al., 2013). These together suggest that MAPK pathway 
mediated cytokine release in TCE sensitization has relevance to human conditions of 
TCE sensitization and the levels of these proinflammatory cytokines may be potential 
biomarkers to reflect the immunological responses to TCE sensitization in OMLDT 
patients. 
In conclusion, we sensitized BALB/c mice through skin challenge with TCE with or 
without pretreatment with the B2R antagonist (HOE140). Liver function and electron 
microscopic examinations proved that there was structural and functional liver 
damage after TCE sensitization. These changes were accompanied by KCs (CD68+) 
activation in the liver. B2R antagonist pretreatment attenuated TCE 
sensitization-induced increase of expressions of phosphorylated ERK, JNK, STAT3 
proteins and inflammatory cytokines IL-1β, IL-6, TNF-α in liver tissue, and alleviated 
the liver injury. These changes were accompanied by upregulated MAPK proteins and 
expressions of their associated pro-inflammatory cytokines in the KCs. The present 
study suggests that KCs activation is involved in the immune liver injury in BALB/c 
mice after TCE sensitization, and BK binding to its receptor B2R can activate MAPK 
signal pathway to mediate pro-inflammatory cytokine expressions in KCs and their 
release to liver tissue in these sensitized mice. The mechanism plays an important role 
in TCE-mediated immunological liver damage. These findings provide new insight 
into molecular mechanisms in TCE sensitization-induced immunological liver 
damage. It is the first such finding on molecular immunological mechanisms in organ 
damage following environmental chemical sensitization and may be fundamental to 
understanding the effect of environmental chemicals on the body with public health 
implications. The sensitization rate of HOE140 did not showed significant difference 
compared with TCE treatment group, and this implies that BK acts on 
post-sensitization pathways for inflammatory amplification through complement 
activation and secondary cytokine release rather than blocking the initial antigen 
presentation process. TCE sensitization may also involve both B2R-dependent and/or 
independent pathways. The effect of directly blocking MAPK activation on the 
pro-inflammatory cytokine release in isolated KCs warrants further study.  
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Figure legends  
Figure 1 Experiment schedule for TCE sensitization in the present study. After 7 days 
of adaptive feeding, 100μl of a mixture of 50% TCE was intradermally injected in 
TCE-treat group; this was defined as the 1st day. On the 4th, 7th and 10th days, 50% 
TCE was painted on the back of the mice for sensitization. On the 17th day and 19th 
day, the mice were challenged twice with 30% TCE. The HOE140 was applied to the 
TCE + HOE140 groups 1 h before the challenge. Animals were euthanized, and 
tissues and samples were taken at 20th day and 22nd day. 
Figure 2 CD68+ and CD16/CD32+ KCs in the liver in TCE mouse model. The 
expression of CD68 and CD16/CD32 in liver tissue was determined by 
immunohistochemical (IHC) staining analysis. 
Figure 3 The expression of BK in plasma in TCE mouse model. aP<0.05, vs. the 
blank control group. 
Figure 4 B2R expression in liver tissue in TCE mouse model. The expression of B2R 
protein in liver tissue was analyzed by Western-blot. aP<0.05, vs. the blank control 
group, bP<0.05, vs. corresponding TCE negative group. 
Figure 5 Double immunofluorescence detection of BK and B2R and antagonistic 
effect of HOE140 in TCE positive group.  
Figure 6 Serum levels of AST and ALT in different groups. aP<0.05, vs. blank control 
group, bP<0.05, vs. corresponding TCE negative group. 
Figure 7 Liver cell ultra-structure changes in the mouse model by transmission 
electron microscope. 
Figure 8 Total P38, ERK1/2, JNK and STAT3 and their phosphorylated proteins 
expressed in liver tissue from TCE sensitized mice. The results were normalized by 
arbitrarily setting the densitometry are expressed as mean ± SD, aP<0.05, vs. the 
blank control group. 
Figure 9 P38, ERK1/2 and JNK and their phosphorylated proteins expressed in 
isolated KCs from the liver in TCE sensitized mice. The results were normalized 
densitometry units and are expressed as mean ± SD, aP<0.05, vs. the blank control 
group.  
Figure 10 Deposition of IL-1β in liver tissue in TCE sensitization mouse model 
detected by IHC. aP<0.05, vs. the blank control group.  
Figure 11 Deposition of IL-6 in liver tissue in TCE sensitization mouse model 
detected by IHC. aP<0.05, vs. the blank control group. 
Figure 12 Deposition of TNF-α in liver tissue in TCE sensitization mouse model 
detected by IHC. aP<0.05, vs. the blank control group. 
Figure 13 The relative mRNA expression of IL-1β, IL-6 and TNF-α in isolated KCs. 
aP<0.05, vs. the blank control group,  cP<0.05, vs. corresponding TCE positive 
group. 
Figure 14 A schematic model of the molecular mechanisms whereby BK and B2R act 
on MAPK pathway to regulate Kupffer cell cytokine release in TCE sensitization 
mouse model.  
 
Table 1. qRT-PCR primer pairs used. 
Primer Sequences 
GAPDH forward 5’-ACCCCAGCAAGGACACTGAGCAAG-3’ 
GAPDH reverse 5’-GGCCCCTCCTGTTATTATGGGGGT-3’ 
IL-1β forward 5′-GAAGAAGAGCCCATCCTC-3’ 
IL-1β reverse 5′-GTTCATCTCGGAGC-CTGTAG-3’ 
TNF-α forward 5’-CCCTCCTGGCCAACGGCATG-3’ 
TNF-α reverse 5’-TCGGGGCAGCCTTGTCCCTT-3’ 
IL-6 forward 5’-CCACTTCACAAGTCGGAGGCTTA-3’ 
IL-6 reverse 5’-GCAAGTGCATCATCGTTGTTCATAC-3’ 
 














